Kaleido Biosciences
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Kaleido Biosciences's balance sheet done over the years? Its assets were worth $0 last year, which is less than in the previous period. null of Kaleido Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $0, which means an decrease by -100% compared compared to last year.

Debt to Assets

Kaleido Biosciences, Inc. (NASDAQ:KLDO): Debt to assets
2016 4990000 21.90M 439%
2017 30747000 74.42M 242.06%
2018 85325000 27.13M 31.8%
2019 82306000 33.42M 40.61%
2020 59344000 38.84M 65.46%
2021 50137000 39.53M 78.84%
2022 0 0

KLDO Balance Sheet (2016 – 2022)

2022 2021 2020 2019 2018 2017 2016
Assets
Current assets:
Cash and cash equivalents
038.47M46.22M71.24M76.08M28.45M2.72M
Short term investments
0000000
Net receivables
00005K45K1.49M
Inventory
0000000
Other current assets
03.83M2.49M2.03M152K50K138K
Total current assets
042.31M46.22M73.27M76.24M28.55M4.36M
Non-current assets:
Property, Plant and Equipment
05.66M8.46M6.74M4.69M1.97M513K
Goodwill
0000000
Intangible assets
0000000
Long term investments
02.16M2.16M2.28M000
Other non-current assets
02.16M4.66M04.38M221K114K
Total non-current assets
07.82M13.12M9.02M9.08M2.19M627K
Total assets
050.13M59.34M82.30M85.32M30.74M4.99M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0828K498K7.08M7.40M2.61M0
Short term debt
016.14M2.63M68K91K104K0
Total current liabilities
029.68M16.65M10.37M11.30M3.85M1.21M
Non-current liabilities:
Long term debt
05.55M18.37M20.39M14.83M14.81M4.95M
Deferred tax
0000000
Other non-current liabilities
04.29M3.81M2.65M998K55.76M15.74M
Total non-current liabilities
09.84M22.18M23.04M15.82M70.57M20.69M
Total liabilities
039.53M38.84M33.42M27.13M74.42M21.90M
Data sourceData sourceData source